This is for example apparent in Acute Myeloid Leukemias where the largest group of patients have normal karyotypes with point mutations (e.g, FLT3ITD, NPM1, IDH1/IDH2 or KRAS/NRAS) and do not cluster on mutation status using gene expression profiles6. This evidence concerns the gene IDH1 and acute myeloid leukemia.